Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Mar 12 2025

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-12-2025-2

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 12, 2025, titled "Glenmark Pharma Expands Cardiometabolic Portfolio with the Launch of Empagliflozin and its Fixed-Drug Combinations in India".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases